Overdosed America

Overdosed America

File:Overdosed America book cover.jpg

Cover of Overdosed America

Overdosed America: The Broken Promise of American Medicine is a book written by Dr. John Abramson, published in 2004. The book critically examines the health care system in the United States, focusing on the influence of the pharmaceutical industry on medical practice and the dissemination of medical information.

Overview

Dr. John Abramson, a family physician and clinical instructor at Harvard Medical School, argues that the American health care system is heavily influenced by the pharmaceutical industry, which prioritizes profit over patient care. The book highlights how drug companies fund clinical trials, influence medical journals, and shape medical education to promote their products.

Key Themes

Influence of Pharmaceutical Companies

Abramson discusses how pharmaceutical companies exert control over the research and publication of clinical trial results. He claims that this leads to biased information being disseminated to physicians and patients, resulting in the over-prescription of medications and the underutilization of more effective, non-pharmaceutical treatments.

The Role of Medical Journals

The book examines the role of medical journals in perpetuating the influence of the pharmaceutical industry. Abramson argues that many journals rely on advertising revenue from drug companies and that this financial dependency can compromise the integrity of published research.

Impact on Medical Education

Abramson also explores how the medical education system is affected by pharmaceutical interests. He suggests that medical schools and continuing medical education programs often receive funding from drug companies, which can lead to biased teaching and a focus on pharmaceutical solutions over other forms of treatment.

Criticism and Reception

Overdosed America received attention for its critical perspective on the American health care system. Some praised the book for shedding light on the issues of conflict of interest and commercialization in medicine, while others criticized it for being overly negative or lacking in solutions.

Related Pages

• Pharmaceutical industry
• Health care in the United States
• Medical ethics
• Clinical trial
• Medical education